ClinicalTrials.govpublic full text
Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer
breast cancer (triple negative breast cancer (tnbc)), breast cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 623531
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.